Issue Date: February 18, 2008
Fujifilm Will Buy Drugmaker Toyama
Film and photocopier maker Fujifilm is entering the pharmaceutical business through the acquisition of most of fellow Japanese firm Toyama Chemical. Fujifilm will spend about $1.45 billion and expects to end up with a 66% stake in the firm. Japan's Taisho Pharmaceutical will hold the rest. Fujifilm says Toyama has a strong new drug pipeline, including T-705, an influenza drug targeted at treating bird flu.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society